From: Multicenter clinical evaluation of a multi-dose formulation of propofol in the dog
Group | Preanesthetic medications1 | Maintenance agent | Number of dogs per group | Duration of procedure (min) Mean ± SD and range2 |
---|---|---|---|---|
1 | None | Multidose propofol | 23 | 14.6 ± 15.8 |
0.3-62 | ||||
2 | Midazolam/buprenorphine | Multidose propofol | 25 | 19.7 ± 14.6 |
2-64 | ||||
3 | Acepromazine/buprenorphine | Multidose propofol | 25 | 18.0 ± 14.3 |
5-56 | ||||
4 | Midazolam/buprenorphine | Inhalant | 22 | 41.1 ± 18.4 |
10-75 | ||||
5 | Acepromazine/buprenorphine | Inhalant | 22 | 73.6 ± 53.1 |
20-203 | ||||
6 | Medetomidine/buprenorphine | Inhalant | 21 | 38.3 ± 20.4 |
7-98 |